A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer
Clinical trial NCT07507526 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07507526
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-04-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.